BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Golias T, Kery M, Radenkovic S, Papandreou I. Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase. Int J Cancer 2019;144:674-86. [PMID: 30121950 DOI: 10.1002/ijc.31812] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 De Rosa V, Iommelli F, Terlizzi C, Leggiero E, Camerlingo R, Altobelli GG, Fonti R, Pastore L, Del Vecchio S. Non-Canonical Role of PDK1 as a Negative Regulator of Apoptosis through Macromolecular Complexes Assembly at the ER-Mitochondria Interface in Oncogene-Driven NSCLC. Cancers (Basel) 2021;13:4133. [PMID: 34439291 DOI: 10.3390/cancers13164133] [Reference Citation Analysis]
2 Echeverri Ruiz NP, Mohan V, Wu J, Scott S, Kreamer M, Benej M, Golias T, Papandreou I, Denko NC. Dynamic regulation of mitochondrial pyruvate metabolism is necessary for orthotopic pancreatic tumor growth. Cancer Metab 2021;9:39. [PMID: 34749809 DOI: 10.1186/s40170-021-00275-4] [Reference Citation Analysis]
3 Yu T, Li G, Wang C, Gong G, Wang L, Li C, Chen Y, Wang X. MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p/HK2/PKM2 axis. RNA Biol 2021;:1-18. [PMID: 34110962 DOI: 10.1080/15476286.2021.1930755] [Reference Citation Analysis]
4 Cho H, Shin I, Cho K, Yoon H, Yoo EK, Kim M, Park S, Lee I, Kim ND, Sim T. Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors. J Med Chem 2019;62:8461-79. [DOI: 10.1021/acs.jmedchem.9b00565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lolak N, Akocak S, Bua S, Sanku RKK, Supuran CT. Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors. Bioorg Med Chem 2019;27:1588-94. [PMID: 30846402 DOI: 10.1016/j.bmc.2019.03.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
6 Pavlu-Pereira H, Lousa D, Tomé CS, Florindo C, Silva MJ, de Almeida IT, Leandro P, Rivera I, Vicente JB. Structural and functional impact of clinically relevant E1α variants causing pyruvate dehydrogenase complex deficiency. Biochimie 2021;183:78-88. [PMID: 33588022 DOI: 10.1016/j.biochi.2021.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Kong S, Ding L, Fan C, Li Y, Wang C, Wang K, Xu W, Shi X, Wu Q, Wang F. Global analysis of lysine acetylome reveals the potential role of CCL18 in non-small cell lung cancer. Proteomics 2021;21:e2000144. [PMID: 33570763 DOI: 10.1002/pmic.202000144] [Reference Citation Analysis]
8 Zhang J, Zheng J, Chen H, Li X, Ye C, Zhang F, Zhang Z, Yao Q, Guo Y, Jin X. Curcumin Targeting NF-κB/Ubiquitin-Proteasome-System Axis Ameliorates Muscle Atrophy in Triple-Negative Breast Cancer Cachexia Mice. Mediators of Inflammation 2022;2022:1-18. [DOI: 10.1155/2022/2567150] [Reference Citation Analysis]
9 Nagao A, Kobayashi M, Koyasu S, Chow CCT, Harada H. HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance. Int J Mol Sci 2019;20:E238. [PMID: 30634433 DOI: 10.3390/ijms20020238] [Cited by in Crossref: 114] [Cited by in F6Publishing: 108] [Article Influence: 38.0] [Reference Citation Analysis]
10 Joseph V, Levine M. Ronald C.D. Breslow (1931-2017): A career in review. Bioorg Chem 2021;115:104868. [PMID: 34523507 DOI: 10.1016/j.bioorg.2021.104868] [Reference Citation Analysis]
11 Zhang J, Zhang L, Nie J, Lin Y, Li Y, Xu W, Zhao JY, Zhao SM, Wang C. Calcineurin inactivation inhibits pyruvate dehydrogenase complex activity and induces the Warburg effect. Oncogene 2021. [PMID: 34667275 DOI: 10.1038/s41388-021-02065-0] [Reference Citation Analysis]
12 Kwak CH, Jin L, Han JH, Han CW, Kim E, Cho M, Chung TW, Bae SJ, Jang SB, Ha KT. Ilimaquinone Induces the Apoptotic Cell Death of Cancer Cells by Reducing Pyruvate Dehydrogenase Kinase 1 Activity. Int J Mol Sci 2020;21:E6021. [PMID: 32825675 DOI: 10.3390/ijms21176021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
13 Sharma NK. A Connecting Switch Among Aging, Diabetes and Tumor: Avenue Leading to Cancer Therapeutics. CCTR 2019;15:170-1. [DOI: 10.2174/1573394714666181022123329] [Reference Citation Analysis]
14 Zeng X, Xu C, Cheng J, Sun C, Wang Z, Gong Z, Long H, Zhu B. Poor glycemic control might compromise the efficacy of chemotherapy in non-small cell lung cancer patients with diabetes mellitus. Cancer Med 2020;9:902-11. [PMID: 31830375 DOI: 10.1002/cam4.2750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Akaki T, Bessho Y, Ito T, Fujioka S, Ubukata M, Mori G, Yamanaka K, Orita T, Doi S, Iwanaga T, Ikegashira K, Hantani Y, Nakanishi I, Adachi T. Fragment-based lead discovery to identify novel inhibitors that target the ATP binding site of pyruvate dehydrogenase kinases. Bioorg Med Chem 2021;44:116283. [PMID: 34274549 DOI: 10.1016/j.bmc.2021.116283] [Reference Citation Analysis]
16 Ye Z, Zeng Z, Shen Y, Yang Q, Chen D, Chen Z, Shen S. ODC1 promotes proliferation and mobility via the AKT/GSK3β/β-catenin pathway and modulation of acidotic microenvironment in human hepatocellular carcinoma. Onco Targets Ther 2019;12:4081-92. [PMID: 31239700 DOI: 10.2147/OTT.S198341] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
17 Imanaka S, Shigetomi H, Kobayashi H. Reprogramming of glucose metabolism of cumulus cells and oocytes and its therapeutic significance. Reprod Sci 2021. [PMID: 33675030 DOI: 10.1007/s43032-021-00505-6] [Reference Citation Analysis]
18 Xu L, Li Y, Zhou L, Dorfman RG, Liu L, Cai R, Jiang C, Tang D, Wang Y, Zou X, Wang L, Zhang M. SIRT3 elicited an anti-Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis. Cancer Med 2019;8:2380-91. [PMID: 30993888 DOI: 10.1002/cam4.2089] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
19 Guo K, Cao Y, Li Z, Zhou X, Ding R, Chen K, Liu Y, Qiu Y, Wu Z, Fang M. Glycine metabolomic changes induced by anticancer agents in A549 cells. Amino Acids 2020;52:793-809. [PMID: 32430875 DOI: 10.1007/s00726-020-02853-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Bessho Y, Akaki T, Hara Y, Yamakawa M, Obika S, Mori G, Ubukata M, Yasue K, Nakane Y, Terasako Y, Orita T, Doi S, Iwanaga T, Fujishima A, Adachi T, Ueno H, Motomura T. Structure-based drug design of novel and highly potent pyruvate dehydrogenase kinase inhibitors. Bioorg Med Chem 2021;52:116514. [PMID: 34808405 DOI: 10.1016/j.bmc.2021.116514] [Reference Citation Analysis]
21 Schoonjans CA, Joudiou N, Brusa D, Corbet C, Feron O, Gallez B. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate. Cancer Lett 2020;470:18-28. [PMID: 31812695 DOI: 10.1016/j.canlet.2019.12.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]